1h Free Analyst Time
This report offers market size & forecast data for the wound biologics market in Europe. The revenue generated from the sale of wound biologics products are included in the report. This report provides a comprehensive and current market scenario of the Europe wound biologics market, including Europe wound biologics market size, anticipated market forecast, relevant market segmentations, and industry trends.Speak directly to the analyst to clarify any post sales queries you may have.
The study considers a detailed scenario of the present wound biologics market and its market dynamics for 2023-2028 in Europe. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET DEFINITIONThe products derived from living organisms or cells for treating wounds are called wound biologics. These are intended to facilitate the re-establishment of innate repair mechanisms.
KEY HIGHLIGHTS- In Europe, the wound biologics market was valued at $420.00 million in 2022 and is expected to reach $710.02 million during the forecast period.
- By End-user, the specialty wound clinics accounted for the highest share of 54.33% in 2022 and are projected to grow at the highest CAGR of 9.51% during the forecast period. This is mainly due to the outsourcing by hospitals for wound treatment.
- By Product type, the biological skin substitutes segment accounted for the highest share of 59.44% in 2022 and is projected to grow at the highest CAGR of 8.81% during the forecast period. The increasing demand for biological skin substitutes is due to the rising number of diabetic wounds, increased preference for wound biologics, and the geriatric population.
- By Wound type, the chronic wounds segment accounted for the highest share of 54.55% in 2022 and is projected to grow at the highest CAGR of 9.64% during the forecast period. This is due to many factors, such as increasing cases of diabetes, obesity, and advanced age, that contribute to the rise in the number of chronic wound cases.
- The demand for wound biologics market is rising due to multiple factors, including an increasing geriatric population, growing consumer awareness regarding usage, high prevalence of chronic and acute wounds, and increasing adoption of wound biologics.
- Other factors such as technological & material advancements, introduction of new products, well-developed healthcare infrastructure, extensive research & development activities, presence of leading key vendors, and government support also contribute to the growth of the overall wound biologics market.
VENDORS LIST- Avita Medical
- Organogenesis
- Smith+Nephew
- Vericel Corporation
- Orthofix
- MediWound
- Aurealis Therapeutics
- Kericis
- MiMedx
- Fidia
- Convatec
- AlloSource
- Cytori
- Ethicon
- Integra LifeSciences
- Medline Industries
- Marine Polymer Technologies
- Molnlycke
- Stryker
- BD
- Zimmer Biomet
- RedDress
PRODUCT SEGMENTATION & FORECASTBy Product
- Biological Skin Substitutes- Growth Factors
By Wound Type
- Chronic Wounds- Acute Wounds
- End-user
- Specialty Wound Care Clinics
- Hospitals
- Long-Term Care Centers
MARKET STRUCTURE- Market Dynamics
- Competitive Landscape of Wound Biologics Market
- Key Vendors
- Other Prominent Vendors
APPENDIX- Research Methodology
- Abbreviations
- About the Analyst
Table of Contents
Chapter - 1: Wound Biologics Market Overview
Chapter - 2: Wound Biologics Market
Chapter - 3: Wound Biologics Market Segmentation Data
Chapter - 4: Key Countries Overview
Chapter - 5: Wound Biologics Market Prospects & Opportunities
Chapter - 6: Wound Biologics Industry Overview
Chapter - 7: Appendix
List of Exhibits
List of Tables
Companies Mentioned
- Avita Medical
- Organogenesis
- Smith+Nephew
- Vericel Corporation
- Orthofix
- MediWound
- Aurealis Therapeutics
- Kericis
- MiMedx
- Fidia
- Convatec
- AlloSource
- Cytori
- Ethicon
- Integra LifeSciences
- Medline Industries
- Marine Polymer Technologies
- Molnlycke
- Stryker
- BD
- Zimmer Biomet
- RedDress
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 76 |
| Published | November 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 0.42 Billion |
| Forecasted Market Value ( USD | $ 0.71 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 22 |
